Exposure to a Deuterated Analogue of Phenylbutyrate Retards S-Phase Progression in HT-29 Colon Cancer Cells
作者:Kevin O. Clarke、Susan M. Ludeman、James B. Springer、O.Michael Colvin、Michael A. Lea、Lawrence E. Harrison
DOI:10.1002/jps.10102
日期:2002.4
Interestingly, exposure of HT-29 colon cancer cells to D4PB resulted in a slowing of S transit, in contrast to butyrate and PB, which induced a G2/M cell cycle block. This difference in cell cycle effect may explain the differences seen in the potency of the phenotypic changes seen with treatment with D4PB. Further studies are needed to elucidate the mechanisms underlying effects of D4PB on the cell cycle.
在不显着影响正常细胞的情况下,诱导肿瘤细胞恢复正常表型和/或引起生长停滞的分化剂代表了癌症治疗的诱人选择。短链脂肪酸的类似物,例如苯丁酸苯酯(PB),已作为临床相关药物进行了研究。为了改善其药代动力学特性,已经研究了PB和其他脂肪酸的结构修饰。我们假设PB的战略性同位素修饰将导致更长的半衰期,从而转化为更有效的临床分化剂。使用结肠癌模型,我们证明与PB和丁酸相比,2,2,3,3-四氘代PB(D4PB)显着增加了细胞凋亡的诱导和细胞增殖的抑制。D4PB对凋亡级联反应的特定调节蛋白表达的影响或D4PB对组蛋白脱乙酰基酶活性的抑制作用无法解释效力的差异。有趣的是,HT-29结肠癌细胞暴露于D4PB导致S转运减慢,而丁酸和PB则引起G2 / M细胞周期阻滞。细胞周期效应的这种差异可以解释用D4PB治疗所见表型变化的效力差异。需要进一步的研究以阐明D4PB对细胞周期的影响的潜在机制。HT-29结肠癌